We Use NK Cells to Fight Disease
At Dragonfly we invent novel therapies that harness the body's
immune system, for vastly improved patient outcomes.
DRAGONFLY IN THE NEWS
Dragonfly Therapeutics Initiates Phase 1/2 Study of its IL12 Immunotherapy in Patients with Advanced Solid Tumors
Dragonfly Therapeutics Announces DF1001 Granted Orphan Drug Designation in the US for Esophageal Cancer
THE LATEST AT DRAGONFLY THERAPEUTICS
Breakthrough Discoveries, Renegade Scientists, and Patients Fighting Disease That We Find Inspiring